Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes.

Albuquerque DC, Neto JD, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, Almeida DR; Investigadores Estudo BREATHE.

Arq Bras Cardiol. 2015 Jun;104(6):433-42. doi: 10.5935/abc.20150031. Epub 2015 Apr 3. English, Portuguese. Erratum in: Arq Bras Cardiol. 2015 Aug;105(2):208.

2.

Mode of death in chronic systolic heart failure: Chagas cardiomyopathy versus systemic arterial hypertension.

Bestetti RB, Otaviano AP, Fantini JP, Cardinalli-Neto A, Nakazone MA, Nogueira PR.

Int J Cardiol. 2014 Jul 1;174(3):818-9. doi: 10.1016/j.ijcard.2014.04.142. Epub 2014 Apr 21. No abstract available.

PMID:
24794968
3.

Prevalence of risk factors for stuttering among boys: analytical cross-sectional study.

Oliveira CM, Nogueira PR.

Sao Paulo Med J. 2014;132(3):152-7. Epub 2014 Apr 14.

4.

Rationale and design: BREATHE registry--I Brazilian Registry of Heart Failure.

BREATHE investigators.

Arq Bras Cardiol. 2013 May;100(5):390-4. doi: 10.5935/abc.20130093. English, Portuguese.

5.

Prognosis of patients with chronic systolic heart failure: Chagas disease versus systemic arterial hypertension.

Bestetti RB, Otaviano AP, Fantini JP, Cardinalli-Neto A, Nakazone MA, Nogueira PR.

Int J Cardiol. 2013 Oct 3;168(3):2990-1. doi: 10.1016/j.ijcard.2013.04.015. Epub 2013 Apr 30. No abstract available.

PMID:
23642596
6.

Parasympathetic impairment in the preclinical stage of chronic Chagas disease.

Bestetti RB, Cardinalli Neto A, Nogueira PR.

Arq Bras Cardiol. 2012 Sep;99(3):867; author reply 868-9. English, Portuguese. No abstract available.

7.

Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry.

Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, Gaxiola E, Albuquerque DC, Corbalán R, Ramos A, Bhatt DL, Steg PG; REACH Latin America Collaborative Group.

Clin Cardiol. 2012 Aug;35(8):451-7. doi: 10.1002/clc.22005. Epub 2012 May 31.

8.

Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy.

Vilas Boas LG, Bestetti RB, Otaviano AP, Cardinalli-Neto A, Nogueira PR.

Int J Cardiol. 2013 Jul 31;167(2):486-90. doi: 10.1016/j.ijcard.2012.01.033. Epub 2012 Feb 23.

PMID:
22365646
9.

Vaccinia viruses isolated from skin infection in horses produced cutaneous and systemic disease in experimentally infected rabbits.

Cargnelutti JF, Schmidt C, Masuda EK, Nogueira PR, Weiblen R, Flores EF.

Res Vet Sci. 2012 Oct;93(2):1070-5. doi: 10.1016/j.rvsc.2011.12.016. Epub 2012 Jan 14.

PMID:
22244689
10.

Impact of right ventricular pacing on patients with Chagas cardiomyopathy with chronic systolic heart failure.

Parra AV, Bestetti RB, Cardinalli-Neto A, Otaviano AP, Nogueira PR.

Int J Cardiol. 2012 Jan 26;154(2):219-20. doi: 10.1016/j.ijcard.2011.10.043. Epub 2011 Nov 21. No abstract available.

PMID:
22104987
11.

Chronic renal impairment in patients with Chagas cardiomyopathy with chronic systolic heart failure: prevalence and prognostic significance.

Ardito SQ, Bestetti RB, Cardinalli-Neto A, Otaviano AP, Nogueira PR.

Int J Cardiol. 2011 Oct 6;152(1):133-4. doi: 10.1016/j.ijcard.2011.07.060. Epub 2011 Aug 17. No abstract available.

PMID:
21852005
12.

Heart rate variability in the frequency domain in chronic Chagas disease: correlation of autonomic dysfunction with variables of daily clinical practice.

Gerbi FC, Takahashi JT, Cardinalli-Neto A, Nogueira PR, Bestetti RB.

Int J Cardiol. 2011 Aug 4;150(3):357-8. doi: 10.1016/j.ijcard.2011.05.042. Epub 2011 Jun 8. No abstract available.

PMID:
21652092
13.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

14.

Epidemiological, clinical e therapeutic profile of heart failure in a tertiary hospital.

Nogueira PR, Rassi S, Corrêa Kde S.

Arq Bras Cardiol. 2010 Sep;95(3):392-8. Epub 2010 Aug 6.

15.

Combination of amlodipine and enalapril in hypertensive patients with coronary disease.

Rienzo M, Saraiva JF, Nogueira PR, Gomes EP, Moretti MA, Ferreira JF, Armagnajian D, Mansur Ade P, Ramires JA, César LA.

Arq Bras Cardiol. 2009 Mar;92(3):173-9, 177-83. English, Spanish.

16.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

17.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

18.

Serum ferritin and obstructive coronary artery disease: angiographic correlation.

de Godoy MF, Takakura IT, Machado RD, Grassi LV, Nogueira PR.

Arq Bras Cardiol. 2007 Apr;88(4):430-3. English, Portuguese.

19.

Mutation analysis of ras gene in the liver of European eel (Anguilla anguilla L.) exposed to benzo[a]pyrene.

Nogueira PR, Lourenço J, Mendo S, Rotchell JM.

Mar Pollut Bull. 2006 Dec;52(12):1611-6. Epub 2006 Jun 2.

PMID:
16828491
20.

The role of gender in the long-term prognosis of patients with myocardial infarction submitted to fibrinolytic treatment.

Nicolau JC, Auxiliadora Ferraz M, Nogueira PR, Coimbra Garzon SA, Serrano CV Jr, Ramires JA.

Ann Epidemiol. 2004 Jan;14(1):17-23.

PMID:
14664775

Supplemental Content

Loading ...
Support Center